AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (October 27, 2006). doi:10.1152/ajpheart.00065.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/H1352    most recent
00065.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brueggemann, L. I
Right arrow Articles by Byron, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brueggemann, L. I
Right arrow Articles by Byron, K. L.
Submitted on January 16, 2006
Accepted on October 25, 2006

Vasopressin Stimulates Action Potential Firing by Protein Kinase C-dependent Inhibition of KCNQ5 in A7r5 Rat Aortic Smooth Muscle Cells

Lioubov I Brueggemann1, Christioher J Moran1, John A Barakat1, Jay Z Yeh2, Leanne L. Cribbs3, and Kenneth L. Byron1*

1 Pharmacology & Experimental Therapeutics and Cardiovascular Institute, Loyola University Chicago, Maywood, Illinois, United States
2 Pharmacology, Northwestern University, Chicago, Illinois, United States
3 Medicine, Loyola University Medical Center, Maywood, Illinois, United States

* To whom correspondence should be addressed. E-mail: kbyron{at}lumc.edu.

[Arg8]-vasopressin (AVP), at low concentrations (10-500 pM), stimulates oscillations in [Ca2+]i (Ca2+ spikes) in A7r5 rat aortic smooth muscle cells. Our previous studies provided biochemical evidence that protein kinase C (PKC) activation and phosphorylation of voltage-sensitive K+ (Kv) channels are crucial steps in this process. In the present study, Kv currents (IKv) and membrane potential were measured using patch clamp techniques. Treatment of A7r5 cells with 100 pM AVP resulted in significant inhibition of IKv. This effect was associated with gradual membrane depolarization, increased membrane resistance, and action potential (AP) generation in the same cells. The AVP-sensitive IKv was resistant to 4-aminopyridine, iberiotoxin, and glibenclamide, but was fully inhibited by the selective KCNQ channel blockers, linopirdine (10 µM) and XE991 (10 µM) and enhanced by the KCNQ channel activator, flupirtine (10 µM). BaCl2 (100 µM) or linopirdine (5 µM) mimicked the effects of AVP on K+ currents, AP generation, and Ca2+ spiking. Expression of KCNQ5 was detected by RT-PCR in A7r5 cells and freshly isolated rat aortic smooth muscle. RNA interference directed toward KCNQ5 reduced KCNQ5 protein expression and resulted in a significant decrease in IKv in A7r5 cells. IKv was also inhibited in response to the PKC activator, 4{beta}-phorbol 12-myristate 13-acetate (10 nM), and the inhibition of IKv by AVP was prevented by the PKC inhibitor, calphostin C (250 nM). These results suggest that the stimulation of Ca2+ spiking by physiological concentrations of AVP involves PKC-dependent inhibition of KCNQ5 channels and increased action potential firing in A7r5 cells.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
A. R. Mackie, L. I. Brueggemann, K. K. Henderson, A. J. Shiels, L. L. Cribbs, K. E. Scrogin, and K. L. Byron
Vascular KCNQ Potassium Channels as Novel Targets for the Control of Mesenteric Artery Constriction by Vasopressin, Based on Studies in Single Cells, Pressurized Arteries, and in Vivo Measurements of Mesenteric Vascular Resistance
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 475 - 483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.